logo-loader
LON:IMM

ImmuPharma PLC

Receive alerts
Market:
LON
Market Cap:
£16.31 m
Price
£0.10
Change
0.62%
52 weeks high
22.50
52 weeks low
8.50

In brief

ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company’s most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.

Insight

Deep dive

ImmuPharma continues to build data package for flagship lupus treatment

Results from a 62-patient follow-up study are due shortly, while data from a 500-person-st...

on 02/25/2019